corindus appoints mark j toland as president and chief executive officer  business wire corindus appoints mark j toland as president and chief executive officer toland brings over  years of healthcare industry operating experience to corindus february  6  pm eastern standard time waltham massbusiness wirecorindus vascular robotics inc corindus or the company nyse mkt cvrs a leading developer of precision vascular robotics today announced that mark toland has been appointed chief executive officer and member of the board of directors replacing david handler who has announced his resignation mr toland joins corindus from boston scientific nyse bsx a global medical technology leader with a significant focus on cardiovascular solutions where he most recently held the position of senior vice president corporate accounts  global healthcare solutions he brings more than  years of operating experience in the cardiovascular medical device industry to corindus mr toland spent more than  years at boston scientific where he led large divisional and corporate teams responsible for us commercial sales and operations across multiple cardiovascular business segments including interventional cardiology peripheral structural heart and electrophysiology mark is a highly respected industry veteran with proven leadership skills and an exceptional track record of growing organizations within the interventional cardiovascular industry said jeffrey lightcap chairman of the board of directors of corindus mark’s deep cath lab insights and strategic vision will be instrumental to leading corindus as we build upon our strong foundation and work to capture the significant potential of robotics in the cath lab commenting on his appointment mark toland said the global opportunity for precision vascular robotics is tremendous i am extremely impressed with the company’s skilled team and unique product offering within large segments of the vascular markets i am excited to join corindus and look forward to working with the healthcare community on enhancing patient outcomes while reducing radiation exposure and ergonomic strain to physicians and healthcare providers mr lightcap added on behalf of the entire board of directors and everyone at corindus we thank david handler for his contributions to corindus which have created a solid foundation for the company’s future success under david’s leadership corindus successfully brought the corpath system® through us regulatory approval and its early commercialization we wish david the best in his future endeavors about corindus vascular robotics inc corindus vascular robotics inc is a global technology leader in roboticassisted percutaneous coronary interventions pcis the company’s corpath system is the first fdacleared medical device to bring roboticassisted precision to pci procedures during the procedure the interventional cardiologist sits at a radiationshielded cockpit to advance stents and guidewires with millimeterbymillimeter precision the cockpit allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries with the corpath system corindus vascular robotics brings robotic precision to radial and complex pci procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual pci procedures corindus stands behind its product with its unique  hospital credit one stent program for additional information visit wwwcorinduscom and follow corindusinc statements made in this release that are not statements of historical or current facts are “forwardlooking statements” within the meaning of the private securities litigation reform act of 99 forwardlooking statements may involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of corindus to be materially different from historical results or from any future results or projections expressed or implied by such forwardlooking statements accordingly readers should not place undue reliance on any forward looking statements in addition to statements that explicitly describe such risks and uncertainties readers are urged to consider statements in the conditional or future tenses or that includes terms such as “believes” “belief” “expects” “estimates” “intends” “anticipates” or “plans” to be uncertain and forwardlooking forwardlooking statements may include comments as to corindus’ beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties many of which are outside corindus’ control examples of such statements include statements regarding the potential benefits of our corpath system and roboticassisted pci for hospitals patients and physicians important factors that could cause actual results to differ materially from those indicated by such forwardlooking statements include among others the rate of adoption of our corpath system and the rate of use of our cassettes risks associated with market acceptance including pricing and reimbursement our ability to enforce our intellectual property rights our need for additional funds to support our operations our ability to manage expenses and cash flow factors relating to engineering regulatory manufacturing sales and customer service challenges potential safety and regulatory issues that could slow or suspend our sales and the effect of credit financial and economic conditions on capital spending by our potential customers more information on potential factors that could affect corindus’ financial results is included from time to time in the “forward looking statements” “risk factors” and “management’s discussion and analysis of financial condition and results of operations” sections of corindus’ periodic and current filings with the sec as well as those discussed under the “risk factors” and “forward looking statements” section of corindus annual report on form 0k filed with the sec on march   and available on corindus’ website at httpwwwcorinduscomaboutcorindusinvestorrelations forward looking statements speak only as of the date they are made corindus undertakes no obligation to publicly update or revise any forwardlooking statements whether as a result of new information future events or otherwise that occur after that date contacts corindus vascular robotics incbrett prince  ext brettprincecorinduscomoryuliya kutuzava  ext corindusknbprcomorlynn pieper lewis 9ircorinduscom release summary mark toland formerly with boston scientific named ceo of corindus vascular robotics inc contacts corindus vascular robotics incbrett prince  ext brettprincecorinduscomoryuliya kutuzava  ext corindusknbprcomorlynn pieper lewis 9ircorinduscom search advanced news search advanced news search log in sign up mark toland corindus vascular robotics inc profile  biography  bloomberg feedback mark toland presidentceo corindus vascular robotics inc career history presidentceo corindus vascular robotics inc 6present senior vpcorporate accounts boston scientific corp unknown6 website wwwcorinduscom corporate information address 9 waverley oaks road suite 0 waltham ma 0 united states phone  fax  web url wwwcorinduscom from the web personal information education university of louisville bachelors degree business administration memberships board memberships corindus vascular robotics inc board member 6present sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data corindus appoints mark j toland as president and chief executive officer  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules0 trading commandments real money access rm rules of investingjim cramers best stocks for 0 commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use 996 thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under 0 top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street corindus appoints mark j toland as president and chief executive officer business wire feb  6  pm est corindus vascular robotics inc corindus or the company nyse mkt cvrs a leading developer of precision vascular robotics today announced that mark toland has been appointed chief executive officer and member of the board of directors replacing david handler who has announced his resignation mr toland joins corindus from boston scientific nyse bsx a global medical technology leader with a significant focus on cardiovascular solutions where he most recently held the position of senior vice president corporate accounts  global healthcare solutions he brings more than  years of operating experience in the cardiovascular medical device industry to corindus mr toland spent more than  years at boston scientific where he led large divisional and corporate teams responsible for us commercial sales and operations across multiple cardiovascular business segments including interventional cardiology peripheral structural heart and electrophysiology mark is a highly respected industry veteran with proven leadership skills and an exceptional track record of growing organizations within the interventional cardiovascular industry said jeffrey lightcap chairman of the board of directors of corindus marks deep cath lab insights and strategic vision will be instrumental to leading corindus as we build upon our strong foundation and work to capture the significant potential of robotics in the cath lab commenting on his appointment mark toland said the global opportunity for precision vascular robotics is tremendous i am extremely impressed with the companys skilled team and unique product offering within large segments of the vascular markets i am excited to join corindus and look forward to working with the healthcare community on enhancing patient outcomes while reducing radiation exposure and ergonomic strain to physicians and healthcare providers mr lightcap added on behalf of the entire board of directors and everyone at corindus we thank david handler for his contributions to corindus which have created a solid foundation for the companys future success under davids leadership corindus successfully brought the corpath system ® through us regulatory approval and its early commercialization we wish david the best in his future endeavors about corindus vascular robotics inc corindus vascular robotics inc is a global technology leader in roboticassisted percutaneous coronary interventions pcis the companys corpath system is the first fdacleared medical device to bring roboticassisted precision to pci procedures during the procedure the interventional cardiologist sits at a radiationshielded cockpit to advance stents and guidewires with millimeterbymillimeter precision the cockpit allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries with the corpath system corindus vascular robotics brings robotic precision to radial and complex pci procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual pci procedures corindus stands behind its product with its unique  hospital credit one stent program for additional information visit wwwcorinduscom and follow corindusinc statements made in this release that are not statements of historical or current facts are forwardlooking statements within the meaning of the private securities litigation reform act of 99 forwardlooking statements may involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of corindus to be materially different from historical results or from any future results or projections expressed or implied by such forwardlooking statements accordingly readers should not place undue reliance on any forward looking statements in addition to statements that explicitly describe such risks and uncertainties readers are urged to consider statements in the conditional or future tenses or that includes terms such as believes belief expects estimates intends anticipates or plans to be uncertain and forwardlooking forwardlooking statements may include comments as to corindus beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties many of which are outside corindus control examples of such statements include statements regarding the potential benefits of our corpath system and roboticassisted pci for hospitals patients and physicians important factors that could cause actual results to differ materially from those indicated by such forwardlooking statements include among others the rate of adoption of our corpath system and the rate of use of our cassettes risks associated with market acceptance including pricing and reimbursement our ability to enforce our intellectual property rights our need for additional funds to support our operations our ability to manage expenses and cash flow factors relating to engineering regulatory manufacturing sales and customer service challenges potential safety and regulatory issues that could slow or suspend our sales and the effect of credit financial and economic conditions on capital spending by our potential customers more information on potential factors that could affect corindus financial results is included from time to time in the forward looking statements risk factors and managements discussion and analysis of financial condition and results of operations sections of corindus periodic and current filings with the sec as well as those discussed under the risk factors and forward looking statements section of corindus annual report on form 0k filed with the sec on march   and available on corindus website at  httpwwwcorinduscomaboutcorindusinvestorrelations  forward looking statements speak only as of the date they are made corindus undertakes no obligation to publicly update or revise any forwardlooking statements whether as a result of new information future events or otherwise that occur after that date if you liked this article you might like these  stocks under 0 are set to soar higher heres a technical look at how to trade several under0 stocks that are poised for breakouts roberto pedone jun  6 0 am edt  stocks under 0 set to soar these stocks trading for less than 0 a share are within range of triggering breakout trades roberto pedone feb  6  am est trending tesla is a cult stock jim cramer says how amazon billionaire jeff bezos gained vast riches and a tech giant someday worth  trillion when stocks fall and its not their fault cramers mad money recap friday  amazon alphabet and a gop failure on healthcare heres where wall street stands ipod nano shuffle are dead here are  other discontinued apple products advertising partners 996 thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers corindus appoints mark j toland as president and chief executive officer corindus appoints mark j toland as president and chief executive officer toland brings over  years of healthcare industry operating experience to corindus tweet february  6  0 pm pst waltham mass business wire  corindus vascular robotics inc corindus or the company nyse mkt cvrs a leading developer of precision vascular robotics today announced that mark toland has been appointed chief executive officer and member of the board of directors replacing david handler who has announced his resignation mr toland joins corindus from boston scientific nyse bsx a global medical technology leader with a significant focus on cardiovascular solutions where he most recently held the position of senior vice president corporate accounts  global healthcare solutions he brings more than  years of operating experience in the cardiovascular medical device industry to corindus mr toland spent more than  years at boston scientific where he led large divisional and corporate teams responsible for us commercial sales and operations across multiple cardiovascular business segments including interventional cardiology peripheral structural heart and electrophysiology mark is a highly respected industry veteran with proven leadership skills and an exceptional track record of growing organizations within the interventional cardiovascular industry said jeffrey lightcap chairman of the board of directors of corindus mark’s deep cath lab insights and strategic vision will be instrumental to leading corindus as we build upon our strong foundation and work to capture the significant potential of robotics in the cath lab commenting on his appointment mark toland said the global opportunity for precision vascular robotics is tremendous i am extremely impressed with the company’s skilled team and unique product offering within large segments of the vascular markets i am excited to join corindus and look forward to working with the healthcare community on enhancing patient outcomes while reducing radiation exposure and ergonomic strain to physicians and healthcare providers mr lightcap added on behalf of the entire board of directors and everyone at corindus we thank david handler for his contributions to corindus which have created a solid foundation for the company’s future success under david’s leadership corindus successfully brought the corpath system® through us regulatory approval and its early commercialization we wish david the best in his future endeavors about corindus vascular robotics inc corindus vascular robotics inc is a global technology leader in roboticassisted percutaneous coronary interventions pcis the company’s corpath system is the first fdacleared medical device to bring roboticassisted precision to pci procedures during the procedure the interventional cardiologist sits at a radiationshielded cockpit to advance stents and guidewires with millimeterbymillimeter precision the cockpit allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries with the corpath system corindus vascular robotics brings robotic precision to radial and complex pci procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual pci procedures corindus stands behind its product with its unique  hospital credit one stent program for additional information visit wwwcorinduscom and follow corindusinc statements made in this release that are not statements of historical or current facts are “forwardlooking statements” within the meaning of the private securities litigation reform act of 99 forwardlooking statements may involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of corindus to be materially different from historical results or from any future results or projections expressed or implied by such forwardlooking statements accordingly readers should not place undue reliance on any forward looking statements in addition to statements that explicitly describe such risks and uncertainties readers are urged to consider statements in the conditional or future tenses or that includes terms such as “believes” “belief” “expects” “estimates” “intends” “anticipates” or “plans” to be uncertain and forwardlooking forwardlooking statements may include comments as to corindus’ beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties many of which are outside corindus’ control examples of such statements include statements regarding the potential benefits of our corpath system and roboticassisted pci for hospitals patients and physicians important factors that could cause actual results to differ materially from those indicated by such forwardlooking statements include among others the rate of adoption of our corpath system and the rate of use of our cassettes risks associated with market acceptance including pricing and reimbursement our ability to enforce our intellectual property rights our need for additional funds to support our operations our ability to manage expenses and cash flow factors relating to engineering regulatory manufacturing sales and customer service challenges potential safety and regulatory issues that could slow or suspend our sales and the effect of credit financial and economic conditions on capital spending by our potential customers more information on potential factors that could affect corindus’ financial results is included from time to time in the “forward looking statements” “risk factors” and “management’s discussion and analysis of financial condition and results of operations” sections of corindus’ periodic and current filings with the sec as well as those discussed under the “risk factors” and “forward looking statements” section of corindus annual report on form 0k filed with the sec on march   and available on corindus’ website at httpwwwcorinduscomaboutcorindusinvestorrelations forward looking statements speak only as of the date they are made corindus undertakes no obligation to publicly update or revise any forwardlooking statements whether as a result of new information future events or otherwise that occur after that date view source version on businesswirecom httpwwwbusinesswirecomnewshome600660en filed in medical cardiology medical products surgery help us maintain quality content — report this story feed email pdf print contact corindus vascular robotics incbrett prince  ext brettprincecorinduscomoryuliya kutuzava  ext corindusknbprcomorlynn pieper lewis 9ircorinduscom more read more stories from corindus vascular robotics inc home  about  dlvrit social  browser extension  contact  api  help  tos add your story   mark j toland  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in mark j toland dir chief executive officer and president at corindus vascular robotics inc view full profile are you mark j toland claim your profile   sign up for equilar atlas and view mark j tolands full profile with equilar atlas you can identify corporate executives in mark j tolands network and community follow changes in mark j tolands employment and moneyinmotion connect with mark j toland through your network of contacts mark j tolands executive work history current dir chief executive officer and president corindus vascular robotics inc past to view mark j tolands complete executive work history sign up now age      mark j tolands biography mark j toland was appointed as our president and chief executive officer and a member of the board of directors effective march  6 on june  6 mr toland was elected to serve as a class iii director until such time as he stands for election at the companys 9 annual meeting of stockholders mr toland joined corindus from boston scientific a global medical technology leader with a significant focus on cardiovascular solutions where he most recently held the position of senior vice president corporate accounts  global healthcare solutions from 99 until joining corindus mr toland led large divisional and corporate teams  read more mark j toland was appointed as our president and chief executive officer and a member of the board of directors effective march  6 on june  6 mr toland was elected to serve as a class iii director until such time as he stands for election at the companys 9 annual meeting of stockholders mr toland joined corindus from boston scientific a global medical technology leader with a significant focus on cardiovascular solutions where he most recently held the position of senior vice president corporate accounts  global healthcare solutions from 99 until joining corindus mr toland led large divisional and corporate teams at boston scientific responsible for us commercial sales and operations across multiple cardiovascular business segments including interventional cardiology peripheral structural heart and electrophysiology since  mr toland has served as a member of the scientific advisory board of the international society of cardiovascular translational research a nonprofit organization founded in 0 with a goal to expedite scientific discovery to clinical application patients mr toland earned a bs in business administration at university of louisville louisville kentucky mr tolands extensive knowledge of the cardiovascular technology space and his experience in bringing new technologies and devices to market makes him wellqualified to serve as the companys president and chief executive officer and a director source corindus vascular robotics inc on 0   sign up for equilar atlas and view mark j tolands full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like mark j toland more specifically youll be able to identify corporate executives in mark j tolands network and community follow changes in mark j tolands employment and moneyinmotion connect with mark j toland through your network of conections view full profile   search for over 60 executive profiles bio example mark j toland mark j tolands connections  sign up now to view mark j tolands  connections » campbell d rogers board member inspiremd inc jeffrey c lightcap board member corindus vascular robotics inc stephen j lemaster chief commercial officer corindus vascular robotics inc jeffrey g gold board member angiodynamics inc david w long former chief financial officer senior vice president treasurer and secretary corindus vascular robotics inc louis a cannon board member corindus vascular robotics inc matthew chiminski former vice president sales and service corindus vascular robotics inc tal wenderow former vice president product and business development corindus vascular robotics inc hillel bachrach former board member corindus vascular robotics inc michael y mashaal former board member corindus vascular robotics inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy 00 marshall street redwood city ca 906  phone 60   fax 60 0099 corindus vascular robotics home careers blog contact us news and events news events media kit press release press releases   february  6 corindus appoints mark j toland as president and chief executive officer toland brings over  years of healthcare industry operating experience to corindus waltham massbusiness wire – corindus vascular robotics inc nyse mkt cvrs a leading developer of precision vascular robotics today announced that mark toland has been appointed chief executive officer and member of the board of directors replacing david handler who has announced his resignation mr toland joins corindus from boston scientific nyse bsx a global medical technology leader with a significant focus on cardiovascular solutions where he most recently held the position of senior vice president corporate accounts  global healthcare solutions he brings more than  years of operating experience in the cardiovascular medical device industry to corindus mr toland spent more than  years at boston scientific where he led large divisional and corporate teams responsible for us commercial sales and operations across multiple cardiovascular business segments including interventional cardiology peripheral structural heart and electrophysiology mark is a highly respected industry veteran with proven leadership skills and an exceptional track record of growing organizations within the interventional cardiovascular industry said jeffrey lightcap chairman of the board of directors of corindus mark’s deep cath lab insights and strategic vision will be instrumental to leading corindus as we build upon our strong foundation and work to capture the significant potential of robotics in the cath lab commenting on his appointment mark toland said the global opportunity for precision vascular robotics is tremendous i am extremely impressed with the company’s skilled team and unique product offering within large segments of the vascular markets i am excited to join corindus and look forward to working with the healthcare community on enhancing patient outcomes while reducing radiation exposure and ergonomic strain to physicians and healthcare providers mr lightcap added on behalf of the entire board of directors and everyone at corindus we thank david handler for his contributions to corindus which have created a solid foundation for the company’s future success under david’s leadership corindus successfully brought the corpath system® through us regulatory approval and its early commercialization we wish david the best in his future endeavors   about corindus vascular robotics inc corindus vascular robotics inc is a global technology leader in roboticassisted vascular interventions the companys corpath system is the first fdacleared medical device to bring robotic precision to interventional procedures during the procedure the interventional cardiologist sits at a radiationshielded workstation to advance guide catheters stents and guidewires with millimeterbymillimeter precision the workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries with the corpath system corindus vascular robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures corindus stands behind its product with its unique  hospital credit one stent program for additional information visit wwwcorinduscom and follow corindusinc forward looking statements statements made in this release that are not statements of historical or current facts are forwardlooking statements within the meaning of the private securities litigation reform act of 99 forwardlooking statements may involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of corindus to be materially different from historical results or from any future results or projections expressed or implied by such forwardlooking statements accordingly readers should not place undue reliance on any forward looking statements in addition to statements that explicitly describe such risks and uncertainties readers are urged to consider statements in the conditional or future tenses or that includes terms such as believes belief expects estimates intends anticipates or plans to be uncertain and forwardlooking forwardlooking statements may include comments as to corindus’ beliefs and expectations as to future event examples of such statements include statements that the level of precision that can be attained using the corpath grx technology combined with the potential for remote capabilities in the future will both expand and improve how patients are treated that corindus has entered a transformational period with a focus on expanding its reach to partner with hospitals to build robotic programs globally that the successful completion of these procedures at fu wai hospital is the first step in corindus growth strategy within china and that the precise positioning enhancements to the corpath platform that allows physicians to adjust guide catheters during pci procedures may expand the use of the corpath grx system to more complex cases media contacts corindus vascular robotics inc kate stanton   ext 0 katestantoncorinduscom investor contact lynn pieper lewis  90 ircorinduscom   read about corindus vascular robotics inc press releases please complete the form below in order to download the content subscribe to our email newsletter please complete the form below in order to download the content please fill out this brief form to subscribe to our email newsletter please fill out this brief form to download the requested multimedia if you would prefer to contact us directly please email contactcorinduscom or call   x 0 please complete the form below and a member of our clinical team will contact you please complete the form below in order to download the content copyright   corindus inc  disclaimer  sitemap thank you for subscribing to our newsletter you will now receive email updates from corindus toland mark j  corindus vascular robotics insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailstoland mark jcorindus vascular robotics cvrspresident and ceo director not rankedtoland mark js performancetoland mark j has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked toland mark js trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datecvrscorindus vascular roboticspresident and ceo directortoland mark j has not reported any informative transactions for cvrs therefore performance cannot be measuredsee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext0 about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext0 where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext06 personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext0 personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext09 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows 0 click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext00 legal privacy  cookies   microsoft